Delivery Order SPE2DX22D0129-SPE2D826F0BTE

The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,745.16 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed price delivery order, which received no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen fulfills medical procurement needs for military and veteran healthcare systems through the delivery of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities.

This delivery order falls under AmerisourceBergen's comprehensive $999.999 billion prime IDC (SPE2DX) with the Defense Logistics Agency, which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive experience supplying diverse therapeutic products including specialty medications, brand-name and generic drugs, and medical devices to federal customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent receipt of competitively awarded, non-set-aside contracts across multiple transaction values reflects its established capability to meet federal medical supply requirements.